Republican Senate Candidate Dom Gentile
Announces Support for #MedicalCannabis Legislation
BIRMINGHAM, Ala. - May 31, 2017 (Investorideas.com Newswire)
Alabama candidate for U.S. Senate, Dom Gentile, today announced his support for
medical cannabis, and is adding this issue to his campaign platform at gentileforsenate.com.
"I have recently met with dozens of people who are stricken
with medical conditions such as epilepsy, seizures, severe autism, Alzheimer's
and MS. Many of them have symptoms that can be relieved by cannabis that is
specifically formulated for medical use. As I listened to the passionate pleas
of these patients and their families, and understood how this can help them, I
became a believer that something needed to be done at the federal level,"
said Gentile. "Medical cannabis is listed as a Schedule 1 controlled
substance under the Controlled Substances Act of 1970. It is in the same class
as heroin and LSD, and that is absurd. I am calling for the FDA and the DEA to
immediately re-classify cannabis for medical use and allow the states to decide
how to dispense the drug."
Read this news in full at http://www.investorideas.com/news/2017/marijuana/05311Medical.asp
Marijuana / Hemp Stocks
Like Marijuana Stocks? View our Marijuana / Hemp
Stocks Directory
Join our Group on Linkedin - Marijuana / Hemp
Stocks - News and Trends in Green Investing
Global
Cannabis Investing -
features Investor Ideas Cannabis news
Get News Alerts on
Marijuana Stocks
Watch
the 420 Cannabis Investor video
More Info:
This news is published on
the Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure: Investorideas.com is a digital
publisher of third party sourced news, articles and equity research as well as
creates original content, including video, interviews and articles. Original
content created by investorideas is protected by copyright laws other than
syndication rights. Our site does not make recommendations for purchases or
sale of stocks, services or products. Nothing on our sites should be construed
as an offer or solicitation to buy or sell products or securities. All
investment involves risk and possible loss of investment. This site is
currently compensated for news publication and distribution, social media and
marketing, content creation and more. Contact each company directly regarding
content and press release questions. Disclosure is posted for each compensated
news release, content published /created if required but otherwise the news was
not compensated for and was published for the sole interest of our readers and
followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding
BC Residents and global Investors: Effective September 15 2008 - all BC
investors should review all OTC and Pink sheet listed companies for adherence
in new disclosure filings and filing appropriate documents with Sedar. Read for
more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
